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DObjective: The late morbidity of pulmonary regurgitation has intensified the interest in valve-sparing repair of
tetralogy of Fallot. This study reviewed a single institution’s experience with valve-sparing repair and investi-
gated the role of intraoperative balloon valvuloplasty.
Methods:A retrospective chart review identified 238 patients who underwent complete primary repair of tetral-
ogy of Fallot at less than 180 days of age. Patients were divided into 4 groups on the basis of the type of right
ventricular outflow tract repair: transannular patch (n ¼ 111), commissurotomy or standard rigid dilation
(n ¼ 71), intraoperative balloon pulmonary valvuloplasty (n ¼ 32), or no valvar intervention (n ¼ 24).
Results: Baseline demographic and anatomic factors differed among the 4 procedural groups with substantial
overlap. Among 142 patients with pulmonary valve hypoplasia (z score,2 to4), 37% had valve-sparing repair.
These patients had significant annular growth over time: z score increased 0.67 and 1.00 per year in the intra-
operative balloon valvuloplasty (P<.001) and traditional valve-sparing (P<.001) groups, respectively. Rates
of valve growth did not differ across groups, but z scores were 0.58 lower for the balloon valvuloplasty group
across all time points (P ¼ .001). Freedom from reintervention and surgery was shorter for the balloon valvu-
loplasty group than for the other groups (P<.001).
Conclusions: Patients with tetralogy of Fallot and pulmonary valve hypoplasia who undergo valve-sparing repair
with intraoperative balloonvalvuloplasty have significant longitudinal annular growth,with normalization of annular
size over time. Despite application in patientswithmore hypoplastic valves, balloonvalvuloplasty resulted in similar
valve growth and pulmonary regurgitation as traditional methods, but higher rates of reintervention. Although the
precise role of this technique needs further refinement, it is likely to be most useful in patients with moderate
pulmonary stenosis and moderate pulmonary valve dysplasia. (J Thorac Cardiovasc Surg 2011;142:1367-73)Tetralogy of Fallot (TOF) may be repaired using a variety of
techniques. In cases of significant pulmonary valve (PV)
hypoplasia, current approaches to right ventricular outflow
tract (RVOT) reconstruction include transannular patch
(TAP), commissurotomy, passage of rigid dilators, valve
augmentation, or reconstruction and sequential intraopera-
tive balloon pulmonary valvuloplasty (IBPV).1-4 TAP
repair, in which the annulus is disrupted and enlarged,
effectively relieves obstruction but results in significant
pulmonary regurgitation (PR). The morbidity of PR over
time has led to greater interest in PV-sparing repair strate-
gies,5-7 but enthusiasm for preserving valve architecture is
balanced with concern for potential residual or recurrent
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The Journal of Thoracic and CarAt the Children’s Hospital, we have pursued a valve-
sparing technique using sharp commissurotomy followed
by IBPV to relieve valvar obstruction in selected patients
during the past 4 years.3 This strategy is based on several the-
oretic advantages and experience with transcatheter pulmo-
nary valvuloplasty in animals and humans. A balloon can
be introduced across the stenotic orifice of the valve and
then expanded to a diameter greater than the valve annulus.
On inflation of the balloon, valve dilation occurs in static po-
sition, and the radial transmission of stress allows not only for
splitting of fused or incomplete leaflet commissures but also,
perhaps ofmore importance, dilation and stretching of the an-
nulus. If the diameter of the balloon is sufficiently large
(120%–140%of themeasuredannulus diameter), the com-
missural tear(s) will often extend into the annulus itself, both
enlarging it acutely and potentially allowing for remodeling
and improved growth.8,9 Prior experience with palliative
transcatheter valvuloplasty in patients with unrepaired TOF
suggests that this technique may produce an increase in PV
annular size beyond that expected with growth alone.10
The present study has 2 goals. The first is to observe and
describe our institutional application of valve-sparing repair
over time, the different modes by which it is achieved, and
the predisposing anatomic and technical factors that may in-
fluence mode of repair. The second is to test the hypothesesdiovascular Surgery c Volume 142, Number 6 1367
Abbreviations and Acronyms
ANOVA ¼ analysis of variance
CI ¼ confidence interval
IBPV ¼ intraoperative balloon pulmonary
valvuloplasty
OR ¼ odds ratio
PR ¼ pulmonary regurgitation
PV ¼ pulmonary valve
RVOT ¼ right ventricular outflow tract
TAP ¼ transannular patch
TOF ¼ tetralogy of Fallot
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Dthat TOF repair with IBPV promotes greater growth of the
hypoplastic PV annulus than standard rigid dilation, with
less resultant PR, and provides relief of RVOT obstruction
comparable to standard rigid dilation or TAP.
MATERIALS AND METHODS
Inclusion Criteria
In accordance with an accepted protocol from the Children’s Hospital
Boston Committee on Clinical Investigation, we performed a single-
center, retrospective chart review of all patients with TOF and pulmonary
stenosis who underwent complete primary repair at less than 180 days of
age between January 1997 and April 2008. Individual patient consent
was waived because of the retrospective nature of the study. Infants who
underwent repair with placement of a right ventricular to pulmonary artery
conduit or who had a history of catheter-based or surgical intervention or
other complex coexisting cardiac disease (eg, complete atrioventricular ca-
nal) were excluded. Patients were divided into groups on the basis of the
operative report description of surgical technique for relief of PVobstruc-
tion. We recognized 4 modes of repair: (1) TAP, (2) commissurotomy or
standard rigid dilation (Hegar), (3) IBPV, and (4) no PV intervention
(none). Patients were included in the group corresponding to the final
mode of PV intervention (ie, patients who underwent initial rigid dilation,
commissurotomy, or IBPV with subsequent intraoperative conversion to
TAP were included in the TAP group). To gain insight into management
of patients with mild to moderate PV hypoplasia, only patients with PV z
scores between2 and4 were included in the analysis.
Baseline and Descriptive Data
Demographic and surgical data included age andweight at repair, date of
repair, surgeon, and categorization of repair technique at each level of the
RVOT (subvalvar, valvar, and supravalvar). Preoperative echocardiographic
data included diameters and z scores of the PV and main and proximal
branch pulmonary arteries. Immediate postoperative and most recent echo-
cardiographic data included degree of PR and continuous-wave Doppler es-
timation of residual RVOT obstruction and right ventricular pressure by
tricuspid regurgitation jet velocity. The timing of and indications for any re-
interventions were recorded, as were any surgical or postoperative deaths.
Comparison of Annular Growth, Valve Competence,
and Residual Right Ventricular Outflow Tract
Obstruction
For patients with significant PV hypoplasia (z score,2 to4) who un-
derwent valve-sparing surgery (IBPV and Hegar groups), the most recent
echocardiogramwas reviewed from each of the following postoperative pe-
riods: immediate (<10 days), short-term (1–6 months), intermediate (61368 The Journal of Thoracic and Cardiovascular Surmonths to 2 years), and long-term (>2 years). For each available study,
an independent observer (DWB or RR) who was blinded to the surgical
technique reported the PV annulus diameter and z score, continuous-
wave Doppler estimation of RVOT gradient and right ventricular pressure
by tricuspid regurgitation jet velocity, and degree of PR (1 ¼ trace,
2 ¼mild, 3 ¼moderate, or 4 ¼ severe). Grading of PR severity was based
on synthesis of color Doppler jet width and flow reversal findings following
previously published criteria.11,12
Statistical Analysis
Baseline differences in age and continuous echocardiographic variables
between groups were tested using 1-way analysis of variance (ANOVA)
with Bonferroni post hoc testing. Changes in PV z scores over time were
assessed using repeated-measures ANOVA, also with application of the
Bonferroni method of multiple comparisons. Differences in PV annular
growth between groups were assessed by 2-way repeated-measures AN-
OVA. A linear mixed-effects model of PVannular growth, which would ac-
count for correlation among repeated measurements on the same subject,
was also constructed. Comparisons of ordinal echocardiographic measures
were performed using Friedman’s test for multiple measurements in the 2
valve-sparing groups and the Kruskal–Wallis test for differences across all
3 groups. Interobserver variability for echocardiographic measurements
was determined by the mean difference and distribution of differences be-
tween paired measurements for continuous variables, and weighted kappa
using linear weights was calculated to assess agreement for ordinal data.
Although a low event rate was anticipated, the times to any RVOT reinter-
vention and to reoperation were estimated according to the method of Ka-
plan andMeier13 and by log-rank testing. Interventions directed at any level
of the RVOTwere counted, but cases of isolated branch pulmonary artery
stenosis were not included. Given the low event rate and causes unrelated to
the RVOT, surgical and postoperative mortality was characterized but not
included in the Kaplan–Meier analysis. Unless noted otherwise, numbers
in parentheses after mean and median values represent standard deviation
and range, respectively.
The authors had full access to and take full responsibility for the integ-
rity of the data. All authors have read and agree to the article as written.
RESULTS
Inception Cohort
A query of the surgical database identified 238 patients
who met inclusion criteria for the descriptive portion of
the study. Baseline age and weight at repair significantly
differed among the 4 procedural groups, with patients hav-
ing TAP undergoing repair at a younger age and smaller size
(Table 1). Overall, 127 patients (53%) had valve-sparing re-
pair. PV and main pulmonary artery z scores were smaller
for the TAP and IBPV groups than for the other 2 valve-
sparing groups (Hegar and none). Patients in the IBPV
group were more likely to undergo supravalvar patch aug-
mentation than patients in the Hegar group (odds ratio
[OR], 2.3; confidence interval [CI], 1.4–3.9; P ¼ .001).
Study Cohort
Of the 238 patients, 142 (60%) had significant PV hypo-
plasia (z score,2 to4) and were included in the experi-
mental analysis (Figure 1). Despite this attempt to create
a more homogenous population, age, weight, and PV and
main pulmonary artery diameter z scores again differed sig-
nificantly between groups, with a pattern similar to the
larger initial cohort.gery c December 2011
TABLE 1. Baseline and procedural characteristics
TAP
n ¼ 111
IBPV
n ¼ 32
Hegar
n ¼ 71
None
n ¼ 24 P value
Age at surgery (d) 74  45*,y 94  35 93  41 103  39 .001
Weight (kg) 4.56  1.46* 5.21  0.89 5.04  1.35 5.42  1.23 .005
PV z score 2.79  0.95*,y 2.40  0.96*,y 1.43  1.09* 0.77  1.20 <.001
Main pulmonary artery z score 2.59  1.07*,y 2.39  1.61*,y 1.45  1.60* 0.05  1.92 <.001
Procedural characteristics
Muscle bundle resection 108 (97%) 31 (97%) 69 (97%) 22 (92%) .56
RVOT patch 108 (97%)*,y 29 (91%) 59 (83%) 15 (63%) <.001
Commissurotomy 18 (16%)y,z 27 (84%)* 41 (58%)* 0 (0%) <.001
Supravalvar patch 108 (97%)*,y,z 18 (56%)*,y 17 (24%) 2 (8%) <.001
*Significantly different from none. ySignificantly different from Hegar. zSignificantly different from IBPV.
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DInterobserver Reliability
For the study portion, 36% of available studies were read
by both blinded observers. There was strong interobserver
agreement between paired measurements for all continuous
variables (mean difference for PV diameter, 0.01 cm [95%
CI,0.03 to 0.06], right ventricular pressure,0.18 mm Hg
[95% CI,0.69 to 0.32], and RVOT gradient, 1.31 mm Hg
[95% CI, 0.26–2.35]), and good agreement for grading of
PR (weighted kappa, 0.72).Intraoperative Balloon Pulmonary Valvuloplasty
Technique
While patients were on cardiopulmonary bypass and after
sharp commissurotomy, a balloon was passed across the PV
and inflated in a static position. The balloon was positionedFIGURE 1. Identification of study groups. TAP, Transannular patch;
IBPV, intraoperative balloon pulmonary valvuloplasty.
The Journal of Thoracic and Carantegrade across the RVOT, except in patients who did not
undergo infundibulotomy and therefore had retrograde dila-
tion (2/32 patients, 6%). The size of the initial dilating bal-
loon was determined by incorporation of the preoperative
echocardiographic PV diameter measurement with intrao-
perative sizing using the largest, easily passable rigid
dilator. In the 23 patients with significant PV hypoplasia
who underwent IBPV, the initial median nominal balloon
size to annulus ratio was 1.33 (0.98–1.67). A median of 2
(1–3) different balloon sizes were used with a final nominal
balloon size to annulus ratio of 1.47 (1.07–1.67). In 7 of 23
patients (30%), the final balloon size was further modulated
by inflation at high pressure (>8 atm). Partial avulsion or
tear of a single valve leaflet required pericardial patch
valvuloplasty without TAP in 2 patients. Ineffective relief
of PV stenosis (n ¼ 1) and annular rupture (n ¼ 2) required
intraoperative conversion to TAP repair in 3 patients. As
mentioned above, patients were included in the group corre-
sponding to the final mode of PV intervention; thus, the lat-
ter 3 patients were included in the TAP experimental group,
as were the 28 patients (28/111, or 25% of TAP group) who
underwent rigid dilation or commissurotomy before intrao-
perative conversion to TAP.Annular Growth
Median PV diameter and z score were increased postop-
eratively and at all subsequent time points in both
PV-sparing groups (P<.001), although PV z scores were
significantly lower in the IBPV group than in the Hegar
group at all time points (P¼ .005). At the most recent avail-
able assessment of PV size, both groups had normalization
(z score,>2) of median PVannulus size (Table 2). Figure 2
illustrates a linear mixed-effects model of annular growth
during the first 3 postoperative years, with PV z score in-
creasing 0.67 per year in the IBPV group (P<.001) and
1.00 per year in the Hegar group (P<.001). On average,
both groups experienced significant PV growth over time,
irrespective of preoperative PV size, but z score was 0.58
lower for the IBPV group (P ¼ .001). The general patterns
of change in z score over time were not different betweendiovascular Surgery c Volume 142, Number 6 1369
TABLE 2. Immediate postoperative and follow-up results for patients with significant preoperative PV hypoplasia (z score,2 to4)
TAP
n ¼ 90
IBPV
n ¼ 23
Hegar
n ¼ 27 P value
Postoperative
PV z score n/a 2.14  0.66 1.34  1.28 .02
Change in PV z score n/a 0.77  0.73 1.09  1.21 .33
RVOT gradient (mm Hg) 20  13y 34  16 26  13 .003
More than mild PR 97% (60/62)*,y 32% (7/22) 52% (11/21) <.001
Severe PR 79% (49/62)*,y 5% (1/22) 14% (3/21) <.001
Follow-up
Median follow-up duration (y) 5.1 (0–11.6)y 1.5 (0.4–3.5) 5.8 (0–11.9)y <.001
PV z score n/a 1.44  1.08 1.07  1.39 .32
RVOT gradient (mm Hg) 21  12 29  13 24  14 .06
More than mild PR 93% (80/86)*,y 50% (10/20) 58% (15/26) <.001
Severe PR 85% (73/86)*,y 15% (3/20) 19% (5/26) <.001
*Significantly different from Hegar. ySignificantly different from IBPV.
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Dthe 2 groups, and the interaction term was not statistically
significant, suggesting that the rates of PV growth were
not different between groups over this time period.
There were insufficient late data to adequately compare
the groups beyond 3 years. Nonlinear models using the
square root and natural log of time, which would assume
more significant early growth, did not provide better fit
than the simple linear model.Resultant Pulmonary Regurgitation and
Reintervention
Postoperatively, 97% of the TAP group had significant
PR, and 32% of the TAP group had IBPV (P < .001,
Table 2). This difference remained significant across all
time points, although at the most recent follow-up, the inci-
dence of significant PR had increased to 50% in the IBPV
group. There were no significant differences in the degree ofFIGURE 2. Linear mixed effects model of PV annular growth over time
shows significant longitudinal growth in both valve-sparing groups
(P<.001 for both Hegar and IBPV), but no significant difference in the
rate or pattern of growth across groups. IBPV, Intraoperative balloon pul-
monary valvuloplasty; PV, pulmonary valve.
1370 The Journal of Thoracic and Cardiovascular SurPR between the IBPV and Hegar groups across all time
points. One patient who had TAP repair underwent early
PV replacement for PR at 8 years of age.Residual Right Ventricular Outflow Obstruction,
Reintervention, and Survival
The RVOT gradient was less in the TAP group than in the
IBPV group postoperatively and approached statistical sig-
nificance (P ¼ .06) at the most recent follow-up (Table 2).
In all study patients, as well as the experimental population
with significant PV hypoplasia, freedom from RVOT rein-
tervention and surgery was significantly shorter for the
IBPV group than the other groups by Kaplan–Meier analy-
sis and log-rank testing (P<.001, Figure 3). PV diameter
and PV z score were not associated with reintervention on
univariate analysis.
Overall, 10 of 142 study patients (7%) underwent rein-
tervention for residual RVOT obstruction. Six patients
(26%) underwent reintervention after IBPV; 2 were suc-
cessfully treated with transcatheter balloon valvuloplasty
alone, and the remaining 4 had surgical treatment for iso-
lated valvar obstruction after unsuccessful catheter-based
therapy (n ¼ 1), subvalvar muscular obstruction (n ¼ 2),
and emergency repair of pulmonary artery laceration sus-
tained during balloon dilation of combined valvar and
supravalvar pulmonary stenosis (n ¼ 1). Two patients
(7%) in the Hegar group underwent reintervention for
RVOT obstruction; 1 had successful transcatheter therapy
and 1 underwent further muscle bundle resection after cath-
eterization. Two patients (2%) in the TAP group had resid-
ual RVOT obstruction at the level of the main and branch
pulmonary arteries, which was successfully treated in the
catheterization laboratory.
In the TAP group, there was 1 operative death due to dis-
seminated pulmonary and coronary artery thromboses.
There were 3 late deaths, 1 in the Hegar group and 2 in
the TAP group. The patient in the Hegar group and 1 ofgery c December 2011
FIGURE 3. Freedom from reintervention and reoperation functions by
PV intervention type for patients with significant PV hypoplasia. Ka-
plan–Meier curves are pictured for the study group only, but were similar
for the entire inception cohort. One intraoperative death in the TAP group is
not included in the analysis but is described in the text. TAP, Transannular
patch.
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malities, multiple congenital anomalies, and airway com-
promise resulting in respiratory failure. The other death in
the TAP group occurred in a patient with diminutive pulmo-
nary arteries who had a complicated postoperative course
significant for failure to separate from bypass, extracorpo-
real membrane oxygenation, multiple catheterizations for
bilateral pulmonary artery stenosis, delayed chest closure,
capillary leak syndrome, and recurrent sepsis. These cases
were not included in the RVOT reintervention analysis.DISCUSSION
The important long-term consequences of PR have re-
framed the question of what constitutes acceptable or man-
ageable residual RVOT obstruction. Several techniques are
used to relieve RVOT obstruction in patients undergoingThe Journal of Thoracic and CarTOF repair, each with different implications for the degree
of residual obstruction and for PV competence. Given these
clinical concerns and the real and theoretic advantages of
IBPV, we have applied this innovative procedure to a hetero-
geneous group of patients during the past 4 years. Retro-
spectively, we compared IBPV with more traditional
surgical methods and analyzed short-term outcomes to learn
more about potential application to the subset of patients
likely to benefit most from this technique. This study repre-
sents our initial experience with the balloon pulmonary val-
votomy technique as a valve-sparing approach to tetralogy
repair in infants.
Descriptive characterization of baseline anatomy and
mode of repair confirmed broad historical variation in sur-
gical decision-making. Among surgeons who performed
at least 10 repairs before the introduction of IBPV (5 sur-
geons, 166 procedures), the percentage of cases in which
a TAP repair was performed ranged from 31% to 80%
among surgeons. There was substantial overlap among all
procedural groups. However, the frequency of valve-
sparing surgery increased over time and must at least in
part reflect growing surgeon preference for PV preserva-
tion. In fact, 2 of the 7 surgeons accounted for the majority
of total valve-sparing procedures (16/23 patients, or 70% of
the IBPV group; 19/27 patients, or 70% of the Hegar group)
but only 38% of all repairs. Furthermore, the more contem-
porary patients with IBPV were anatomically similar to pa-
tients with TAP, with significantly more RVOT hypoplasia
than those who underwent traditional rigid dilation or com-
missurotomy. This is reflected in the lower preoperative PV
z score in the IBPV group compared with the Hegar group.
It is not surprising that the IBPVand TAP groups were also
more likely to have concomitant supravalvar intervention.
This suggests that for valve-sparing TOF surgery to gain
more acceptance among surgeons, precise morphologic cri-
teria should be identified that can guide surgical therapy.
The prenatal and preoperative quantitative anatomy of
unrepaired TOF has been well defined and is widely vari-
able across each level of the RVOT and between individ-
uals.14-16 Although several groups have demonstrated
PV growth after palliative balloon valvuloplasty for
unrepaired TOF,10,17,18 little is currently known about
annular growth after complete PV-sparing repair. Surgical
reports focused on valve-sparing strategies have reported
generally good outcomes,19-22 but longitudinal assessment
of PV size is limited and described in mildly hypoplastic
cohorts.20,22 In our study, all patients who underwent PV-
sparing surgery had significant longitudinal annular growth,
with eventual normalization of PV annular diameter over
time, and a lower incidence of significant PR than in TAP
repair. Counter to our study hypothesis, the IBPV group
did not experience significantly greater annular growth or
have significantly less postoperative PR than patients who
had commissurotomy or rigid dilation. However, IBPVdiovascular Surgery c Volume 142, Number 6 1371
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sia across all time points.
Despite substantial PVannular growth and normalization
of PV hypoplasia, IBPV was associated with higher short-
term reintervention rates compared with TAP, suggesting
that annular dimension is not the sole determinant of suc-
cessful valve-sparing repair. Although reintervention after
IBPV was predominantly for residual RVOT obstruction,
only 3 of 6 patients (50%) required reintervention for iso-
lated valvar obstruction. Two of these patients had
catheter-based therapy alone, whereas the single patient
who had surgical reintervention had a dysplastic-
appearing valve with only mild PV annular hypoplasia (z
score,2.63) at the time of reoperation. This is consistent
with prior observation that valve morphology may be an im-
portant determinant of PV-sparing repair.19 Moreover, the
other 50% of patients requiring reintervention had subval-
var (n ¼ 2) and combined valvar and supravalvar obstruc-
tion (n ¼ 1). Finally, PV diameter and PV z score were
not associated with reintervention.
These findings are further evidence that treatment of an-
nular hypoplasia is only one of several important factors in
achieving successful PV-sparing repair and have already
prompted considerable changes in surgical technique as
the IBPV procedure has evolved. Inadequate commissurot-
omy, under-aggressive balloon dilation, incomplete muscle
bundle resection, and, in particular, failure to patch the
supravalvar area have all been raised as potential contribu-
tors to higher short-term reintervention rates. We have sub-
sequently modified the supravalvar incision, extending it in
a T-shape into the commissures of the PVand extending the
infundibular patch into the commissures. Further evaluation
of these more recent modifications is required to determine
their efficacy in preventing reintervention for residual or re-
current outflow obstruction.
Although TAP was associated with the lowest reinterven-
tion rate, these patients had a greater degree of PR. The
higher degree of residual RVOT obstruction associated
with IBPV is concerning; however, the long-term effects
of moderate RV pressure overload in repaired TOF remain
less certain22 than those associated with severe PR5-7 and
deserve ongoing follow-up. In addition, the proportion of
patients with residual RVOTobstruction who were success-
fully treated by catheter-based therapy alone (33% of all
patients requiring intervention after IBPV, 66% of patients
with isolated valvar obstruction) may be a compelling argu-
ment for further refinement.
Given the desire to preserve valve competence, the sig-
nificant PV growth with normalization of hypoplasia after
IBPV, and the relative success of catheter-based therapy,
this technique may have an evolving role as an additional
tool to achieve valve-sparing repair in selected patients, par-
ticularly those with a PV z score between2.5 and3.5 and
who might have received a TAP previously.1372 The Journal of Thoracic and Cardiovascular SurCONCLUSIONS
Patients with TOF and significant PV hypoplasia who
have valve-sparing repair with IBPV, rigid dilation, or com-
missurotomy have significant longitudinal PV growth, with
normalization of annular size over time. IBPV resulted in
similar PV growth and postoperative PR as traditional
methods, despite being used in a more hypoplastic patient
cohort. In this initial series that included our learning curve,
IBPV was associated with higher degrees of residual RVOT
obstruction, and consequently higher rates of reinterven-
tion, than TAP repair or traditional valve-sparing tech-
niques, but it is an evolving technique that merits further
refinement and study.
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